Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Oncogene permanent activation in a single targeted cell of zebrafish together with a reprogramming factor transient activation is sufficient to induce the malignant transformation of the cell and ...

The prospective, epidemiologic School Inner-City Asthma Study (SICAS) evaluated potential biomarkers of inflammation associated with radon exposure among children aged 4 to 13 years with persistent ...

Protein signatures provide critical insights into underlying biological mechanisms and play a pivotal role in identifying actionable biomarkers. The ability to measure multiple proteins simultaneously ...

Molecular Infectious Disease Testing Market. Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Molecular Infectious Disease ...

The isothermal nucleic acid amplification technology market has evolved significantly due to the growing need for decentralized and point-of-care diagnostics. The increasing emphasis on rapid ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, ...

Speaking at a recent Technology Networks’ symposium, Dr. Jason Reeves explained how AI is changing the development of ...